Pharmaceuticals - , California, United States
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program in early 2018.
Outlook
Sage Intacct
GoDaddy Hosting
Adobe Marketing Cloud